For patients with more aggressive disease, the addition of chemotherapy to the ARPI/ADT backbone may optimize efficacy outcomes without comprising safety. In a Medical Crossfire session at the 19th ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results